Andrea Pace

8.4k total citations · 1 hit paper
170 papers, 4.7k citations indexed

About

Andrea Pace is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Andrea Pace has authored 170 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Genetics, 66 papers in Pulmonary and Respiratory Medicine and 38 papers in Oncology. Recurrent topics in Andrea Pace's work include Glioma Diagnosis and Treatment (100 papers), Brain Metastases and Treatment (49 papers) and Cancer Treatment and Pharmacology (21 papers). Andrea Pace is often cited by papers focused on Glioma Diagnosis and Treatment (100 papers), Brain Metastases and Treatment (49 papers) and Cancer Treatment and Pharmacology (21 papers). Andrea Pace collaborates with scholars based in Italy, Malaysia and United States. Andrea Pace's co-authors include B. Jandolo, C. M. Carapella, Alessandra Fabi, Antonello Vidiri, Alfredo Pompili, Veronica Villani, Marta Maschio, Loredana Bove, Francesco Cognetti and Stefano Telera and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrea Pace

162 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

2018 257 citations Giuseppe Lombardi, Gian Luca De Salvo et al. profile →

Peers

Countries citing papers authored by Andrea Pace

Since Specialization

Citations

This map shows the geographic impact of Andrea Pace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Pace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Pace more than expected).

Fields of papers citing papers by Andrea Pace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Pace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Pace. The network helps show where Andrea Pace may publish in the future.

Co-authorship network of co-authors of Andrea Pace

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Pace. A scholar is included among the top collaborators of Andrea Pace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Pace. Andrea Pace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement 2025 ·Journal of Neuro-Oncology ·Angela Mastronuzzi, (unknown), (unknown), (unknown), Giulia Berzero, (unknown), Massimo Filippi, Gaetano Lanzetta, Enrico Marchioni, Claudia Milanaccio, Matteo Simonelli, Paola Bini, Antonio Silvani, Andrea Pace	0
2	Inside a Metastatic Fracture: Molecular Bases and New Potential Therapeutic Targets 2025 ·Cancer Medicine ·(unknown), Andrea Sambri, Michele Fiore, (unknown), (unknown), Andrea Pace, (unknown), Alberto Montanari, Alberta Cappelli, (unknown), Massimiliano De Paolis	0
3	Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action 2024 ·Brain Sciences ·Antonio Malvaso, (unknown), Luca Diamanti, Matteo Gastaldi, Elisa Vegezzi, Andrea Pace, Paola Bini, Enrico Marchioni	6
4	Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2 2023 ·Cell Death and Disease ·Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, Michele Signore, Barbara Ascione, Elisabetta Iessi, Aymone Gurtner, Andrea Sacconi, Lucia Ricci‐Vitiani, Roberto Pallini, Andrea Pace, Veronica Villani, Andrea Polo, (unknown), Alfredo Budillon, Gennaro Ciliberto, Marco G. Paggi	8
5	A Combined Use of Custom-Made Partial Pelvic Replacement and Proximal Femur Megaprosthesis in the Treatment of Severe Bone Loss after Multiple Total Hip Arthroplasty Revisions 2023 ·SHILAP Revista de lepidopterología ·Michele Fiore, (unknown), (unknown), (unknown), Alberto Montanari, Andrea Pace, (unknown), (unknown), (unknown), Massimiliano De Paolis, Andrea Sambri	1
6	Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma 2022 ·Cells ·(unknown), Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, (unknown), Veronica Villani, Andrea Pace, Marco G. Paggi	14
7	Prognostication in brain tumors 2022 ·Handbook of clinical neurology ·Andrea Pace, (unknown), Dario Benincasa	15
8	Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response 2021 ·Journal of Experimental & Clinical Cancer Research ·Silvia Matteoni, Paola Matarrese, Barbara Ascione, Lucia Ricci‐Vitiani, Roberto Pallini, Veronica Villani, Andrea Pace, Marco G. Paggi, Claudia Abbruzzese	42
9	Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas 2020 ·Neuro-Oncology ·Marco Rossi, Lorenzo Gay, Federico Ambrogi, Marco Conti Nibali, Tommaso Sciortino, Guglielmo Puglisi, Antonella Leonetti, (unknown), Manuela Caroli, Susanna Cordera, Matteo Simonelli, Federico Pessina, Piera Navarria, Andrea Pace, Riccardo Soffietti, Roberta Rudà, Marco Riva, Lorenzo Bello	79
10	Efficacy and safety of eculizumab in patients with neuromyelitis optica spectrum disorder previously treated with rituximab: findings from PREVENT 2020 ·Multiple Sclerosis Journal ·Miles Levy, Achim Berthele, (unknown), (unknown), Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline Palace, S J Pittock, (unknown), N. А. Totolyan, (unknown), (unknown), Andrea Pace, Marcus Yountz, D. Scott Lawson, (unknown), Dean M. Wingerchuk	4
11	Regional outcomes of eculizumab treatment in patients with aquaporin-4 immunoglobin G-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study 2020 ·European Journal of Neurology ·Celia Oreja‐Guevara, Jacqueline Palace, S J Pittock, Achim Berthele, (unknown), Miles Levy, Ichiro Nakashima, Andrea Pace, Larisa Miller, (unknown), Dean M. Wingerchuk	1
12	The influence of patient sex on clinical approaches to malignant glioma 2019 ·Cancer Letters ·Silvia Matteoni, Claudia Abbruzzese, Veronica Villani, Walter Malorni, Andrea Pace, Paola Matarrese, Marco G. Paggi	24
13	Impact of eculizumab on reported quality of life in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the PREVENT study 2019 ·Multiple Sclerosis Journal ·Achim Berthele, S J Pittock, (unknown), (unknown), Miles Levy, Jacqueline Palace, Ichiro Nakashima, (unknown), N. А. Totolyan, (unknown), (unknown), Andrea Pace, K Fujita, Marcus Yountz, (unknown), Dean M. Wingerchuk, (unknown)	2
14	REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib activity in relapsed glioblastoma patients 2017 ·Annals of Oncology ·Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes, Marica Eoli, Roberta Rudà, Marina Faedi, Ivan Lolli, Andrea Pace, (unknown), Domenico Germano, (unknown), Miriam Farina, Giovanna Magni, Ardi Pambuku, Eleonora Bergo, Giulio Cabrini, Stefano Indraccolo, Marina Paola Gardiman, Vittorina Zagonel	3
15	Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients 2014 ·Neurosurgical FOCUS ·Alfredo Pompili, Stefano Telera, Veronica Villani, Andrea Pace	46
16	Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma 2012 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Andrea Pace, F. M. Solivetti, (unknown), (unknown), Claudio Bonifati	4
17	Quality of Care and Rehospitalization Rate in the Last Stage of Disease in Brain Tumor Patients Assisted at Home: A Cost Effectiveness Study 2012 ·Journal of Palliative Medicine ·Andrea Pace, Cherubino Di Lorenzo, (unknown), Veronica Villani, Dario Benincasa, (unknown), Maurizio Salvati, Christian Brogna, (unknown), (unknown), Alfredo Pompili	48
18	Epilepsy in the end-of-life phase in patients with high-grade gliomas 2012 ·Journal of Neuro-Oncology ·Andrea Pace, Veronica Villani, Cherubino Di Lorenzo, (unknown), Marta Maschio, Alfredo Pompili, C. M. Carapella	41
19	Outcome and tolerability of topiramate in brain tumor associated epilepsy 2007 ·Journal of Neuro-Oncology ·Marta Maschio, Loredana Dinapoli, Alessia Zarabla, Alfredo Pompili, C. M. Carapella, Andrea Pace, Diana Giannarelli, E. Occhipinti, B. Jandolo	59
20	Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients 1997 ·Neurological Sciences ·Andrea Pace, Loredana Bove, (unknown), Marco Nardi, A Pietrangeli, F. Calabresi, P. Innocenti, B. Jandolo	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact